Global 3D Bioprinting Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Component (3D Bioprinters (Microextrusion bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting and Other technologies), Bioinks (Natural Bioinks, Hybrid Bioinks and Synthetic Bioinks)), Application, Material, and Region - Industry Forecast from 2024 to 2029

Updated On: January, 2024
ID: 10348
Pages: 170

3D Bioprinting Market Size (2023 to 2028)

The global 3D Bioprinting market is forecasted to grow at a CAGR of 21.2% between 2023 to 2028 and be worth USD 1724 million by 2028 from USD 659.2 million in 2023.

3D bioprinting is a process that aims at creating biomedical parts imitating the nature of tissue-like structures in the body used in the process of tissue engineering. 3D printing uses cells, biomaterials, and growth factors to fabricate these biomedical parts. Layers and layers of bio-inks are used to create tissue-like structures. 3D bioprinting can print organs and tissues for treatments, drug research, and transplants and create scaffold material used to regenerate tissues and ligaments. 

Impact of COVID-19 on the global 3D bioprinting market:

The COVID-19 pandemic leads to more R&D to counter the SARS-CoV-2 virus and find a cure in the form of vaccines and drugs for the deadly pandemic. The emergency lockdown situations lead to difficulty in obtaining much equipment, especially in the healthcare sector. 3D bioprinting helped with this crisis. the 3D printing assisted in producing more COVID-19 test swabs, respiratory devicesventilators, and face shields, all of which were scarce during the pandemic. 

COVID-19 has accelerated the growth rate of the 3D bioprinting market. Along with the production of equipment, the 3D printing technology helped print the lung tissues, which supported the virus's growth for researchers to study the virus better. Thus, the pandemic benefitted the market for 3D bioprinting. However, as the research activities became more focused on COVID-19, the other research subjects were side-lined, and so were the issues of 3D bioprinting. In addition, ever since the impact of COVID-19, it has become more critical to conduct drug testing to ensure the safety of the consumers, which has positively impacted the market.

MARKET DRIVERS:

The technological advancements drive the 3D bioprinting market along with increased research and development and government funding in the area.

The scarcity of organ donors, the rising geriatric population, and chronic diseases that need organ transplantation drive the 3D bioprinting market growth. It was mentioned in organdonor.gov each day, 17 people die waiting for an organ transplant. Additionally, the production of medicinal equipment and several support products during the COVID-19 pandemic led the market to grow further. Furthermore, the rising acceptance and Application of 3D bioprinting technologies in cosmetology and pharmaceuticals are expected to promote market growth.

The increasing demand for 3D bioprinting in the healthcare industry drives market growth.

The growing number of complex organ transplantations such as heart, kidneys, and lungs are favoring the 3D bioprinting market growth. Sometimes, the immune system of the body rejects organ transplantation when taken from another body. The chances for rejections are very less when using 3D bioprinting in the process. A 3D rating standard is required in bone fractures where tissue engineering is needed during the procedure. Therefore, the growing penetration of 3D bioprinting in the healthcare industry is boosting the growth rate of the worldwide 3D bioprinting market.

Furthermore, the growing advancements in 3D bioprinting, increasing investments for R&D and rising adoption of regenerative medicine are supporting the growth rate of the 3D bioprinting market.

MARKET RESTRAINTS:

However, the complexity of the 3D bioprinting procedure and the high costs of production and management associated with the field, along with a lack of skilled and knowledgeable professionals in the study, will prove to be a hindrance to the market. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2022 to 2028

Base Year

2022

Forecast Period

2023 to 2028

Segments Covered

Based on Component, Application, Material, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global 3D Bioprinting market has been segmented and sub-segmented based on the product, end-user, and region.

3D Bioprinting Market - By Component:

  • 3D Bioprinters
    • Microextrusion bioprinting
    • Inkjet 3D Bioprinting
    • Laser-assisted Bioprinting
    • Magnetic 3D Bioprinting
    • Other technologies
  • Bio inks
    • Natural Bio inks
    • Hybrid Bio inks
    • Synthetic Bio inks

The 3D bioprinters segment is expected to dominate the market during the forecast period due to the Inkjet and Magnetic Bioprinting subsegments and their wide usage across the industry. The growth of the Ink-jet 3D bioprinting technology is due to its wide applications in the healthcare sector and usage in tissue engineering and drug delivery systems. Ink-jet systems help print complex living cells quickly and accurately, driving segmental growth.

However, due to their comparatively lower prices and precise results, the magnetic 3d bioprinting segment is also expected to witness growth during the forecast period. In addition, they help eradicate any errors in 3d bioprinting and can help in tissue regeneration projects promoting the segment's growth. However, the invention of newer technologies may slow the segment's growth. 

3D Bioprinting Market - By Application:

  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Application
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other Clinical Applications

Based on the Application, the clinical application segment accounted for the leading share of the 3D bioprinting market in 2022. It is expected to expand at a growing CAGR during the forecast period. In addition, the expanding demand for pharmaceuticals and the efficient bio-drug service in this technology boosts the growth rate of the segment.

The fastest CAGR in the market is anticipated for the tissue and organ generation sub-segment during the forecast period. The most common application of 3D bioprinting in medicine is regenerating organs and tissue suitable for transplantation. In addition, the need for tissue and organ creation is growing as the COVID-19 disease is becoming more common. Therefore, the tissue and organ generation segment is anticipated to experience exponential expansion throughout the forecast period. 

3D Bioprinting Market - By Material:

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Biomaterials

Based on Material, the living cells segment accounted for the largest market share due to the increased R&D in this sector and rising governmental and private expenditure on research. Additionally, living cells 3d bioprinting has a wide range of applications in the healthcare sector and is used for research and treatment purposes, supporting the segment's growth. 

However, the hydrogels segment is also expected to show significant growth in the market during the forecast period due to the several advantages of hydrogels in 3d bioprinting. One advantage is that hydrogels can generate a flexible and hydrated cross-linked network. Like the natural extracellular matrix in which cells may live, hydrogels are therefore regarded as the gold standard materials for 3D bioprinting. Furthermore, the polymers used to make hydrogels can be divided into synthetic and natural polymers expanding the uses of the Material and promoting segment growth. 

3D Bioprinting Market - By End User:

  • Research Organization & Academic Institutes
  • Biopharmaceuticals Companies
  • Hospital

Based on the end-user, the biopharmaceutical companies segment has a huge demand for 3D bioprinting. One of the key factors supporting the segment's growth is the increasing demand for implants for treatment and a rise in the number of chronic diseases worldwide. As a result, the segment will represent more than 45% of the market throughout the forecast period.

However, the research organizations and academic institutes segment is also expected to dominate the market during the forecast period due to the rising support from the government toward research through funding and the spread of awareness. Additionally, the growing availability of resources for students and researchers to continue research promotes segment growth.

3D Bioprinting Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Geographically, the North American market had the highest share of the global market in 2022 and is anticipated to hold the most significant share of the worldwide market during the forecast period owing to the growing adoption of healthcare IT in the North American region. The growing investments from North American countries to conduct R&D to develop effective medical devices, vaccines and drugs are favoring the 3D bioprinting market growth in North America. Due to the growing penetration of drug testing and organ transplantation, the demand for 3D bioprinting is growing significantly and is also providing lucrative growth opportunities to the market participants of 3D bioprinting.

The market in the Asia Pacific had a substantial share of the global 3D bioprinting market in 2022 and is anticipated to register the fastest CAGR during the forecast period among all the regions. China, India and Japan held the major share of the APAC market in 2021 and the domination of these countries is likely to be continuing during the forecast period. The increasing R&D spending by the APAC countries is one of the major factors fuelling the regional market growth. The growing penetration of technology in the APAC healthcare industry and increasing incidence of organ transplantations are further promoting the growth rate of the APAC bioprinting market. During the forecast period, the Chinese market is expected to have a healthy CAGR.

During the forecast period, the European market is anticipated to witness a prominent CAGR.

TOP COMPANIES IN THIS MARKET:

Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies Pte. Ltd., Regenovo Biotechnology Co. Ltd., Optomec Inc., GE Healthcare, ExOne, Electro-Optical Systems, Renishaw Ltd., Stratasys Ltd., EnvisionTEC, Cyfuse Biomedical K.K., Formlabs, Inc., Organovo Holdings Inc., and Allevi Inc. are a few of the prominent players in the global 3D bioprinting market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

  • In May 2022, Allegro 3D Inc. was purchased by BICO Group AB. With this acquisition, BICO Group AB is aiming to have a strong footprint in the market by leveraging the light-based 3D bioprinting technology of Allegro 3D.

4202

When I submit this form, I am consenting to Market Data Forecast Privacy Policy.

Frequently Asked Questions

How much was the global 3D bioprinting market worth in 2022?

The global 3D bioprinting market size was valued at USD 659.2 million in 2022.

Which segment by application led the 3D bioprinting market?

Based on the application, the clinical application segment dominated the 3D bioprinting market in 2022.

Which region is anticipated to grow the fastest in the global 3D bioprinting market?

Geographically, the APAC regional market is predicted to register the fastest CAGR in the global market.

Which are the top players in the global 3d Bioprinting market?

Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies Pte. Ltd., Regenovo Biotechnology Co. Ltd., Optomec Inc., GE Healthcare, ExOne (S. Kent Rockwell], Electro-Optical Systems, Renishaw ltd., Stratasys Ltd., EnvisionTEC, Cyfuse Biomedical K.K., Formlabs, Inc., Organovo Holdings Inc. and Allevi Inc. are some of the notable players in the global 3D bioprinting market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample